Skip to main content

Table 3 Comparison between Choi and RECIST criteria at 2 months in the ITT2 population (N = 35)

From: RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study

 Responders (Choi)Non-Responders (Choi)Total
SD (RECIST 1.1)11920
PD (RECIST 1.1)7815
Total181735